Sutton Wealth Advisors’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-6
Closed -$153 868
2023
Q2
$153 Hold
6
﹤0.01% 837
2023
Q1
$178 Sell
6
-31
-84% -$900 ﹤0.01% 786
2022
Q4
$1K Sell
37
-457
-93% -$11.2K ﹤0.01% 1322
2022
Q3
$10.8K Buy
494
+457
+1,235% +$11.9K ﹤0.01% 866
2022
Q2
$1.01K Sell
37
-293
-89% -$8.42K ﹤0.01% 1280
2022
Q1
$11.1K Sell
330
-432
-57% -$13.9K ﹤0.01% 906
2021
Q4
$26.4K Buy
762
+109
+17% +$3.52K 0.01% 625
2021
Q3
$20.4K Buy
653
+29
+5% +$984 0.01% 689
2021
Q2
$22.7K Buy
624
+462
+285% +$19.1K 0.01% 668
2021
Q1
$7.09K Hold
162
﹤0.01% 953
2020
Q4
$7.43K Sell
162
-15
-8% -$624 ﹤0.01% 895
2020
Q3
$5.88K Hold
177
﹤0.01% 876
2020
Q2
$5.2K Sell
177
-25
-12% -$724 ﹤0.01% 871
2020
Q1
$5.44K Buy
202
+88
+77% +$2.63K ﹤0.01% 799
2019
Q4
$3.84K Hold
114
﹤0.01% 980
2019
Q3
$4.27K Hold
114
﹤0.01% 966
2019
Q2
$4.97K Hold
114
﹤0.01% 934
2019
Q1
$4.87K Hold
114
﹤0.01% 940
2018
Q4
$5.11K Buy
114
+25
+28% +$1.31K ﹤0.01% 886
2018
Q3
$6.1K Sell
89
-7
-7% -$450 ﹤0.01% 875
2018
Q2
$5.5K Hold
96
﹤0.01% 911
2018
Q1
$4.42K Buy
96
+25
+35% +$1.19K ﹤0.01% 933
2017
Q4
$3.28K Hold
71
﹤0.01% 932
2017
Q3
$3.2K Sell
71
-12
-14% -$512 ﹤0.01% 915
2017
Q2
$3.26K Hold
83
﹤0.01% 920
2017
Q1
$3.16K Hold
83
﹤0.01% 899
2016
Q4
$3.07K Hold
83
﹤0.01% 896
2016
Q3
$2.88K Sell
83
-9
-10% -$315 ﹤0.01% 895
2016
Q2
$2.99K Hold
92
﹤0.01% 860
2016
Q1
$2.64K Buy
+92
New +$2.45K ﹤0.01% 852

Other funds holding AVNS

Sutton Wealth Advisors's AVNS Position: Q3 2023 in Review

Sutton Wealth Advisors sold out of Avanos Medical (AVNS) in Q3 2023, closing a stake of 6 shares — an estimated $153 sold.

Sutton Wealth Advisors first reported a position in AVNS in Q1 2016 and held it in 30 quarters. The position peaked at $26.4K in Q4 2021. 260 funds tracked by Wall St. Rank hold AVNS as of Q3 2023.

  • Sutton Wealth Advisors reported no remaining Avanos Medical position as of Q3 2023 after selling out during the quarter.
  • Sutton Wealth Advisors sold 6 Avanos Medical shares in Q3 2023, an estimated $153.
  • Sutton Wealth Advisors first reported a position in Avanos Medical in Q1 2016 and held it in 30 quarters.
  • Sutton Wealth Advisors's Avanos Medical position peaked at $26.4K in Q4 2021.
  • 260 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2023.

Based on Sutton Wealth Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.